TETRAVARINEX Trademark

Trademark Overview


On Thursday, May 30, 2013, a trademark application was filed for TETRAVARINEX with the United States Patent and Trademark Office. The USPTO has given the TETRAVARINEX trademark a serial number of 79132921. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, February 26, 2021. This trademark is owned by GW Pharma Limited. The TETRAVARINEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary pharmaceutical preparations, namely, herbs, herbal extracts, formulas containing herbal extracts, medicinal oils and pure extracts of medicinal plants and herbs, for use in the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, epilepsy, dravet syndrome, neonatal hypoxia, seizures, alzheimers, bone disorders, drug, alcohol and nicotine abuse, inflammatory disorders, protection of pancreatic islet cells in the treatment of diabetic or pre-diabetic patients, protection of ...
tetravarinex

General Information


Serial Number79132921
Word MarkTETRAVARINEX
Filing DateThursday, May 30, 2013
Status709 - CANCELLED - SECTION 71
Status DateFriday, February 26, 2021
Registration Number4582222
Registration DateTuesday, August 12, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2014

Trademark Statements


Goods and ServicesPharmaceutical and veterinary pharmaceutical preparations, namely, herbs, herbal extracts, formulas containing herbal extracts, medicinal oils and pure extracts of medicinal plants and herbs, for use in the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, epilepsy, dravet syndrome, neonatal hypoxia, seizures, alzheimers, bone disorders, drug, alcohol and nicotine abuse, inflammatory disorders, protection of pancreatic islet cells in the treatment of diabetic or pre-diabetic patients, protection of beta cells in the treatment of diabetic or pre-diabetic patients, maintenance of insulin levels, improved control of blood glucose levels, treatment of type I diabetes, treatment of type II diabetes; pharmaceutical and veterinary pharmaceutical preparations for the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, epilepsy, dravet syndrome, neonatal hypoxia, seizures, alzheimers, bone disorders, drug, alcohol and nicotine abuse, inflammatory disorders, protection of pancreatic islet cells in the treatment of diabetic or pre-diabetic patients, protection of beta cells in the treatment of diabetic or pre-diabetic patients, maintenance of insulin levels, improved control of blood glucose levels, treatment of type I diabetes, treatment of type II diabetes; herbs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW Research Limited
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressGB

Party NameGW Pharma Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGB

Party NameGW Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalisbury, Wiltshire SP4 0JQ
GB

Party NameGW Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalisbury, Wiltshire SP4 0JQ
GB

Trademark Events


Event DateEvent Description
Monday, January 30, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, December 28, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, December 28, 2022INVALIDATION PROCESSED
Wednesday, November 24, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Wednesday, October 9, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, August 12, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, September 13, 2018CHANGE OF OWNER RECEIVED FROM IB
Thursday, December 21, 2017NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, November 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 15, 2016INTERNATIONAL REGISTRATION RENEWED
Thursday, September 24, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Friday, June 19, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, January 30, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, January 6, 2015FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, January 6, 2015FINAL DISPOSITION PROCESSED
Wednesday, November 12, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 12, 2014REGISTERED-PRINCIPAL REGISTER
Friday, June 13, 2014NOTIFICATION PROCESSED BY IB
Tuesday, May 27, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 27, 2014PUBLISHED FOR OPPOSITION
Wednesday, May 7, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 7, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 7, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 22, 2014WITHDRAWN FROM PUB - ESU SUPERVISOR REQUEST
Tuesday, April 22, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 18, 2014ASSIGNED TO LIE
Friday, March 28, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 24, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 24, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 24, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 2, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 2, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, October 20, 2013REFUSAL PROCESSED BY IB
Wednesday, September 25, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 25, 2013REFUSAL PROCESSED BY MPU
Tuesday, September 24, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 23, 2013NON-FINAL ACTION WRITTEN
Sunday, September 15, 2013ASSIGNED TO EXAMINER
Friday, July 26, 2013APPLICATION FILING RECEIPT MAILED
Monday, July 22, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 18, 2013SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB